Ignite Creation Date:
2024-05-05 @ 6:33 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509340
Status:
TERMINATED
Last Update Posted:
2013-06-21
First Post:
2007-07-30
Brief Title:
Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy
Sponsor:
RAND
Organization:
RAND
Study Overview
Official Title:
Cognitive Behavioral Adherence Intervention for Depressed HIV Patients
Status:
TERMINATED
Status Verified Date:
2013-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Inability to recruit enough eligible participants at study site
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the effectiveness of a cognitive behavioral intervention versus usual clinic care in helping HIV infected adults with depression to take their HIV medications on schedule
Detailed Description:
Antiretroviral therapy ART is a type of medication treatment for HIV that impairs the viruss ability to multiply When used properly it has been shown to be successful in reducing HIV-related deaths A high adherence rate to ART is required to adequately suppress the virus limit drug resistance and reduce transmission HIV infected people who are depressed often experience increased difficulty with adhering to their ART regimen This study will compare the effectiveness of a cognitive behavioral intervention that targets both depression and adherence versus usual care practices which may or may not include mental health intervention with the goal of improving ART adherence among HIV infected adults with depression who are experiencing difficulty with adhering to their medication regimen
This study will last 24 weeks Participants will be randomly assigned to receive the cognitive behavioral intervention or usual care Study visits for all participants will occur at baseline and Weeks 4 8 16 and 24 Those receiving the intervention will also have visits at Weeks 1 and 2 Participants receiving the intervention will attend five individual treatment sessions followed by one to three booster treatment sessions these sessions will coincide with the study visits
This study will last 24 weeks Participants will be randomly assigned to receive the cognitive behavioral intervention or usual care Study visits for all participants will occur at baseline and Weeks 4 8 16 and 24 Those receiving the intervention will also have visits at Weeks 1 and 2 Participants receiving the intervention will attend five individual treatment sessions followed by one to three booster treatment sessions these sessions will coincide with the study visits
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R34MH077503 | NIH | None | None |
| DAHBR 9A-ASNM | US NIH GrantContract | None | httpsreporternihgovquickSearchR34MH077503 |